The Experts below are selected from a list of 855 Experts worldwide ranked by ideXlab platform

Yu R Aliyarov - One of the best experts on this subject based on the ideXlab platform.

  • Factors associated with rectal Tumor and their influence on Tumor regression grade after neoadjuvant chemoradiotherapy
    ECO-vector, 2018
    Co-Authors: Yu R Aliyarov
    Abstract:

    Aim. To determine relation between localization, grade of invasion and differentiation in rectal Tumor and Tumor regression grade after neoadjuvant chemoradiation therapy. Methods. 88 patients with local advanced rectal cancer (Т2-4N0-2М0) were analyzed: 46 females and 42 males. The average age was 52.4±1.4 years. All patients underwent neoadjuvant chemoradiotherapy. In all groups regardless of Tumor localization patients with stage T3 and moderate differentiation grade predominated. Results. Complete pathological Tumor response of grade 4 (TRG4) was revealed in 13 (14.7%) patients, grade 3 (TRG3) in 34 (38.6%) patients, low treatment effect (Tumor response grade 2, TRG2) was registered in 26 (29.5%) patients, and lack of treatment effect (grade 1, TRG1) in 15 (17.2%) patients. Analysis of the data from patients with complete or nearly complete Tumor regression (grade 3 and 4) demonstrated that such effect of neoadjuvant treatment was most often observed in patients with Tumor localized in rectal lower ampulla (58.6%). Among patients with moderately differentiated adenocarcinomas, patients with Tumor response of grade 3 and 4 predominated: 28 (56%) patients. According to invasion grade, in all groups patients with therapeutic response grade 3 and 4 prevailed, but most prominently - in groups of patients with stage T4a and T4b - 58.9%. Conclusion. The closer to Anus Tumor is located, the more significant effect neoadjuvant therapy has; moderate Tumor differentiation grade can be considered as a relative predictive factor of Tumor regression on preoperative chemoradiation therapy